118 related articles for article (PubMed ID: 36916388)
1. Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β.
Dash SR; Das B; Das C; Sinha S; Paul S; Pradhan R; Kundu CN
Nanomedicine (Lond); 2023 Jan; 18(1):19-33. PubMed ID: 36916388
[TBL] [Abstract][Full Text] [Related]
2. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.
Dash SR; Das C; Das B; Jena AB; Paul S; Sinha S; Tripathy J; Kundu CN
Nanomedicine (Lond); 2024 Mar; 19(7):581-596. PubMed ID: 38293827
[No Abstract] [Full Text] [Related]
3. NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells.
Dash SR; Chatterjee S; Sinha S; Das B; Paul S; Pradhan R; Sethy C; Panda R; Tripathy J; Kundu CN
Nanomedicine; 2022 Feb; 40():102502. PubMed ID: 34843984
[TBL] [Abstract][Full Text] [Related]
4. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
[TBL] [Abstract][Full Text] [Related]
5. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.
Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN
Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881
[TBL] [Abstract][Full Text] [Related]
6. Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer.
Hembram KC; Chatterjee S; Sethy C; Nayak D; Pradhan R; Molla S; Bindhani BK; Kundu CN
Mol Pharm; 2019 Jul; 16(7):3011-3023. PubMed ID: 31145852
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
[TBL] [Abstract][Full Text] [Related]
8. Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition.
Zuo ZQ; Chen KG; Yu XY; Zhao G; Shen S; Cao ZT; Luo YL; Wang YC; Wang J
Biomaterials; 2016 Mar; 82():48-59. PubMed ID: 26751819
[TBL] [Abstract][Full Text] [Related]
9. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination.
Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789
[TBL] [Abstract][Full Text] [Related]
10. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.
Wang SE; Xiang B; Guix M; Olivares MG; Parker J; Chung CH; Pandiella A; Arteaga CL
Mol Cell Biol; 2008 Sep; 28(18):5605-20. PubMed ID: 18625725
[TBL] [Abstract][Full Text] [Related]
14. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
Bhola NE; Balko JM; Dugger TC; Kuba MG; Sánchez V; Sanders M; Stanford J; Cook RS; Arteaga CL
J Clin Invest; 2013 Mar; 123(3):1348-58. PubMed ID: 23391723
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.
Pradhan R; Paul S; Das B; Sinha S; Dash SR; Mandal M; Kundu CN
J Nutr Biochem; 2023 Mar; 113():109257. PubMed ID: 36572069
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
Wang Y; Yu Y; Tsuyada A; Ren X; Wu X; Stubblefield K; Rankin-Gee EK; Wang SE
Oncogene; 2011 Mar; 30(12):1470-80. PubMed ID: 21102523
[TBL] [Abstract][Full Text] [Related]
17. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Hyun SY; Le HT; Min HY; Pei H; Lim Y; Song I; Nguyen YTK; Hong S; Han BW; Lee HY
Theranostics; 2021; 11(6):2932-2952. PubMed ID: 33456581
[No Abstract] [Full Text] [Related]
18. Genome-Editing-Mediated Restructuring of Tumor Immune Microenvironment for Prevention of Metastasis.
Kim D; Wu Y; Shim G; Oh YK
ACS Nano; 2021 Nov; 15(11):17635-17656. PubMed ID: 34723493
[TBL] [Abstract][Full Text] [Related]
19. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.
Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X
J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.
Tang B; Yoo N; Vu M; Mamura M; Nam JS; Ooshima A; Du Z; Desprez PY; Anver MR; Michalowska AM; Shih J; Parks WT; Wakefield LM
Cancer Res; 2007 Sep; 67(18):8643-52. PubMed ID: 17875704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
